Self-assembled peptide nucleic acids

US10446768B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10446768-B2
Application numberUS-201715648524-A
CountryUS
Kind codeB2
Filing dateJul 13, 2017
Priority dateMay 2, 2013
Publication dateOct 15, 2019
Grant dateOct 15, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Ordered (e.g., self-assembled) structures, arranged from peptide nucleic acids and/or analogs thereof, are disclosed. The peptide nucleic acids forming the ordered structures comprise from 1 to 10 PNA backbone units, at least one comprising a guanine nucleobase or an analog thereof. Processes of generating the ordered structures, uses thereof and articles-of manufacturing, devices and systems containing same are also disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A process of generating a composition-of-matter comprising a plurality of peptide nucleic acids arranged in an ordered nanometric or micrometric structure, each of said peptide nucleic acids independently comprising 1 to 10 backbone units, at least one of said backbone units comprising a guanine nucleobase or an analog thereof, the process comprising contacting said plurality of peptide nucleic acids with an aqueous solution under conditions which favor formation of said ordered nanometric or micrometric structure, said aqueous solution having a pH greater than 8. 2. The process of claim 1 , wherein said contacting is such that a concentration of said peptide nucleic acids in said aqueous solution ranges from 10 mg/ml to 100 mg/ml. 3. The process of claim 2 , wherein said concentration is about 50 mg/ml. 4. The process of claim 1 , wherein each of said peptide nucleic acids independently comprises 2 to 6 of said backbone units. 5. The process of claim 1 , wherein each of said peptide nucleic acids comprises 2 of said backbone units and is being a peptide nucleic acid dimer (PNA dimer). 6. The process of claim 5 , wherein each of said peptide nucleic acid dimers is independently selected from the group consisting of AG, CG, GG, GA, GC, and GT. 7. The process of claim 5 , wherein each of said peptide nucleic acid dimers is AG, and wherein said ordered structure is a ribbon-shaped micrometric structure. 8. The process of claim 5 , wherein each of said peptide nucleic acid dimers is CG, and wherein said ordered structure is a fibrillar micrometric structure. 9. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GG, and wherein said ordered structure is a clustered spherical micrometric structure. 10. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GA, and wherein said ordered structure is a micrometric or nanometric folded sheet structure. 11. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GC, and wherein said ordered structure is a fibrillar micrometric structure. 12. The process of claim 5 , wherein each of said peptide nucleic acid dimers is GT, and wherein said ordered structure is a fractal porous nanometric or micrometric structure. 13. The process of claim 1 , wherein said aqueous solution comprises a buffer having pH greater than 8. 14. The process of claim 1 , wherein said aqueous solution comprises a polyamine. 15. The process of claim 14 , wherein a concentration of said polyamine in said aqueous solution ranges from 0.1% to 10%, by volume. 16. The process of claim 1 , wherein said ordered structure is formed at an elongation rate of at least 1 micron per second. 17. The process of claim 1 , wherein at least 10 9 molecules of said peptide nucleic acids organize into said ordered nanometric or micrometric structure per second.

Assignees

Inventors

Classifications

  • C07K14/003Primary

    Peptide-nucleic acids (PNAs) · CPC title

  • containing organic luminescent materials · CPC title

  • containing oxygen as the only heteroatom · CPC title

  • containing nitrogen as the only heteroatom · CPC title

  • Electricity · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10446768B2 cover?
Ordered (e.g., self-assembled) structures, arranged from peptide nucleic acids and/or analogs thereof, are disclosed. The peptide nucleic acids forming the ordered structures comprise from 1 to 10 PNA backbone units, at least one comprising a guanine nucleobase or an analog thereof. Processes of generating the ordered structures, uses thereof and articles-of manufacturing, devices and systems c…
Who is the assignee on this patent?
Univ Ramot
What technology area does this patent fall under?
Primary CPC classification C07K14/003. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).